VENUE

HOTEL RESERVATIONS

The Westin Galleria Dallas

13340 Dallas Pkwy

Dallas, TX 75240 

Onsite Health & Safety Measures

shutterstock_711100342.jpg

GALA remains diligent in ensuring that the safety and security of our attendees, speakers and staff are top priority while planning the conference. As we move ahead with planning the conference, GALA will continue to place high importance on facilitating measures that will ensure optimal health and sanitary conditions for everyone onsite during the event. Our onsite safety measures, include the following:

  • Social distancing will be strictly followed with a limited number of attendees onsite.

  • Attendees must wear a face covering during the event.

  • Attendees are required to be six feet apart at all times; the conference organizers have arranged seating accordingly to be in compliance with this mandate.

  • Hand sanitizer stations have been placed throughout the outdoor meeting space, as well as in the hotel.

  • Signage is being used throughout the meeting space and hotel as a reminder to wear a mask and maintain social distance.

  • Commonly touched surfaces will be cleaned and disinfected by staff as often as possible.

  • Check-in for the event will be socially distanced and managed by the conference organizers for a “touchless” process.

  • Audience questions will be asked through our conference App in order to eliminate contact through handheld microphones.

  • To ensure the safety of our speakers, in between speaker presentations, there will be a slight delay while the podium, slide advancer, and microphone cover are sanitized.

  • All meals and break items will be pre-packaged and for individual use only. Individually rolled silverware and single use condiments will be available, as well as modifications of existing menus to meet the safest presentation possible. 

  • In addition to the safety measures outlined above, please click here for a complete list of safety measures that the Westin Galleria Dallas has implemented.

This activity is supported by educational grants from AbbVie, Allergan Inc., Dova Pharmaceuticals, Gilead, Intercept Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals and Takeda Pharmaceuticals U.S.A., Inc.

Jointly provided by the Annenberg Center for Health Sciences 
at Eisenhower, the Gastrointestinal and Liver Association of the Americas (GALA), and the Texas Liver Institute.

  • Facebook Social Icon
  • Twitter Social Icon

© 2020 GI and Liver Association of the Americas